Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Singapore’s Medtech Thought Leader Role And ASEAN Update

Executive Summary

Singapore drives much of the medtech regulatory and policy thought leadership in the ASEAN region, as shown in its regulatory collaboration with Thailand and actions on cybersecurity and packaging waste.

You may also be interested in...



Singapore Consults On Medtech UDI System

Singapore’s devices regulator is seeking comments on recently issued draft guidance on a medical device Unique Device Identification system.

Global Medtech Guidance Tracker: April 2021

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Thirty-two guidance documents have been posted on the tracker since its last update.

Thailand Issues New Medtech Regulations – Industry Guidelines To Follow

More parts of the Thai FDA’s new medtech regulations will come into force in mid-March, following the first tranche last month. Other changes will become effective later in 2021 and certain elements of the system remain a work in progress.

Topics

UsernamePublicRestriction

Register

MT144037

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel